Urology & Urogynecology 5 mins NHS England Reimburses Optilume® Urethral Drug Coated Balloon as Part of the Specialised Services Device Programme Laborie welcomed the inclusion of Optilume® Urethral Drug-Coated Balloon (DCB)... Written By Laborie
Urology & Urogynecology 3 mins Laborie Unveils Positive Study Results for Optilume® BPH Catheter System Laborie announced positive 2-year and 5-year results from studies for... Written By Laborie
General News | Urology & Urogynecology 3 mins Optilume® BPH Catheter System Issued Category 1 CPT Code by American Medical Association Laborie Medical Technologies Corp (Laborie), announced today that the American... Written By Laborie
Urology & Urogynecology 3 mins Optilume Drug-Coated Balloon Shows Long-Term Efficacy for Urethral Strictures: Five-Year Data Published in the Journal of Urology Laborie Medical Technologies Corp. (Laborie), a leader in diagnostic and... Written By Laborie
Urology & Urogynecology 4 mins Three-Year Data from ROBUST III Confirms Long-Term Durability of Optilume® Drug-Coated Balloon for Recurrent Urethral Strictures Laborie Medical Technologies Corp. (Laborie), a global leader in diagnostic... Written By Laborie
Urology & Urogynecology 4 mins Laborie’s Optilume® Drug-Coated Balloon for Stricture Secures Coverage from BCBS of Michigan Effective July 1, 2025, Blue Cross Blue Shield of Michigan... Written By Laborie
